Corvus Pharmaceuticals Files 8-K on Shareholder Vote Matters

Ticker: CRVS · Form: 8-K · Filed: Jun 13, 2025 · CIK: 1626971

Corvus Pharmaceuticals, Inc. 8-K Filing Summary
FieldDetail
CompanyCorvus Pharmaceuticals, Inc. (CRVS)
Form Type8-K
Filed DateJun 13, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-governance, shareholder-vote

Related Tickers: CRVS

TL;DR

Corvus Pharma (CRVS) filed an 8-K on shareholder vote matters. Keep an eye on governance.

AI Summary

Corvus Pharmaceuticals, Inc. filed an 8-K on June 13, 2025, reporting on matters submitted to a vote of security holders as of June 12, 2025. The filing details the company's corporate structure, including its state of incorporation (Delaware) and fiscal year end (December 31).

Why It Matters

This filing indicates that Corvus Pharmaceuticals held a vote of its security holders, which could pertain to significant corporate decisions or governance changes.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of a shareholder vote and does not contain immediate financial or operational risks.

Key Players & Entities

  • Corvus Pharmaceuticals, Inc. (company) — Registrant
  • June 12, 2025 (date) — Date of earliest event reported
  • June 13, 2025 (date) — Date of report
  • Delaware (jurisdiction) — State of incorporation

FAQ

What specific matters were submitted to a vote of Corvus Pharmaceuticals' security holders?

The filing does not specify the exact matters voted upon, only that 'Submission of Matters to a Vote of Security Holders' is the item being reported.

When was the earliest event reported in this 8-K filing?

The earliest event reported was on June 12, 2025.

What is Corvus Pharmaceuticals' principal executive office address?

The principal executive offices are located at 901 Gateway Boulevard, Third Floor, South San Francisco, CA 94080.

What is Corvus Pharmaceuticals' IRS Employer Identification Number?

The IRS Employer Identification Number for Corvus Pharmaceuticals is 46-4670809.

What is the SIC code for Corvus Pharmaceuticals?

The Standard Industrial Classification (SIC) code for Corvus Pharmaceuticals is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 13, 2025 regarding Corvus Pharmaceuticals, Inc. (CRVS).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.